Works matching IS 25094254 AND DT 2024 AND VI 8 AND IP 1

Results: 12

Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 115, doi. 10.1007/s41669-023-00447-6

By:

Costin, Jeremy;
Mouslim, Morgane C.;
Socal, Mariana P.;
Trujillo, Antonio

Publication type:

Article

Specialist Palliative Care and Health Care Costs at the End of Life.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 31, doi. 10.1007/s41669-023-00446-7

By:

Kenny, Patricia;
Liu, Dan;
Fiebig, Denzil;
Hall, Jane;
Millican, Jared;
Aranda, Sanchia;
van Gool, Kees;
Haywood, Philip

Publication type:

Article

Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 91, doi. 10.1007/s41669-023-00445-8

By:

Favre-Bulle, Andrea;
Huang, Min;
Haiderali, Amin;
Bhadhuri, Arjun

Publication type:

Article

Acknowledgement to Referees.

Published in:: PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 1, doi. 10.1007/s41669-023-00456-5
Publication type:: Article

The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 5, doi. 10.1007/s41669-023-00455-6

By:

Macabeo, Bérengère;
Rotrou, Théophile;
Millier, Aurélie;
François, Clément;
Laramée, Philippe

Publication type:

Article

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 119, doi. 10.1007/s41669-023-00454-7

By:

Verbeek, Joost G. E.;
van der Sluis, Karen;
Vollebergh, Marieke A.;
van Sandick, Johanna W.;
van Harten, Wim H.;
Retèl, Valesca P.

Publication type:

Article

Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH).

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 133, doi. 10.1007/s41669-023-00453-8

By:

DuBrock, Hilary M.;
Germack, Hayley D.;
Gauthier-Loiselle, Marjolaine;
Linder, Jörg;
Satija, Ambika;
Manceur, Ameur M.;
Cloutier, Martin;
Lefebvre, Patrick;
Panjabi, Sumeet;
Frantz, Robert P.

Publication type:

Article

Preferences for Living Arrangements in Dementia: A Discrete Choice Experiment.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 65, doi. 10.1007/s41669-023-00452-9

By:

Speckemeier, Christian;
Abels, Carina;
Höfer, Klemens;
Niemann, Anja;
Wasem, Jürgen;
Walendzik, Anke;
Neusser, Silke

Publication type:

Article

Cost of Patients with Alzheimer's Disease in Spain According to Disease Severity.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 103, doi. 10.1007/s41669-023-00451-w

By:

Gómez Maldonado, Laura;
de Mora-Figueroa, Ricardo;
López-Angarita, Angélica;
Maravilla-Herrera, Paulina;
Merino, María

Publication type:

Article

Developing a Natural History Model for Duchenne Muscular Dystrophy.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 79, doi. 10.1007/s41669-023-00450-x

By:

Broomfield, Jonathan;
Hill, M.;
Chandler, F.;
Crowther, M. J.;
Godfrey, J.;
Guglieri, M.;
Hastie, J.;
Larkindale, J.;
Mumby-Croft, J.;
Reuben, E.;
Woodcock, F.;
Abrams, K. R.

Publication type:

Article

United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 49, doi. 10.1007/s41669-023-00448-5

By:

King, Madeleine T.;
Revicki, D. A.;
Norman, R.;
Müller, F.;
Viney, R.C.;
Pickard, A. S.;
Cella, D.;
Shaw, J. W.;
Aaronson, Neil;
Brazier, John;
Cella, David;
Costa, Daniel;
Fayers, Peter;
Grimison, Peter;
Janda, Monika;
Kemmler, Georg;
Luo, Nan;
McTaggart-Cowan, Helen;
Mercieca-Bebber, Rebecca;
Norman, Richard

Publication type:

Article

Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE<sup>®</sup>) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 1, p. 19, doi. 10.1007/s41669-023-00432-z

By:

Fauchier, Laurent;
Lamblin, Nicolas;
Tardu, Jean;
Bellier, Lucile;
Groyer, Harinala;
Ittah, Deborah;
Chollet, Julien;
Linden, Stephan;
Levy, Pierre

Publication type:

Article